oxynitidine has been researched along with camptothecin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agama, K; An, LK; Hu, DX; Kiselev, E; Marchand, C; Ofori-Atta, K; Pommier, Y; Ravji, A; Tang, WL; Wang, HW; Yang, H; Zhang, XR; Zhang, Y | 1 |
| Agama, K; An, LK; Chen, JW; Hu, DX; Pommier, Y; Tang, WL; Yang, H; Yu, Q; Zhang, Y | 1 |
2 other study(ies) available for oxynitidine and camptothecin
| Article | Year |
|---|---|
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; DNA Cleavage; DNA Topoisomerases, Type I; Drug Design; Humans; Models, Molecular; Phenanthridines; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2018 |
Synthesis and biological evaluation of 5-aminoethyl benzophenanthridone derivatives as DNA topoisomerase IB inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzophenanthridines; Breast Neoplasms; Cell Line, Tumor; DNA Damage; DNA Topoisomerases, Type I; Drug Screening Assays, Antitumor; Humans; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Protein Binding; Structure-Activity Relationship; Topoisomerase I Inhibitors; Xenograft Model Antitumor Assays | 2019 |